Thus, as bevacizumab induced a correlation between Ktrans and Tie2 shortly after treatment started and the trajectories of the two Tie2 clusters mirrored changes in tumor Ktrans but not CK18, the data imply that Tie2 reflects bevacizumab-induced tumor vascular modulation. Here, KRT18 is linked to neoplasm.